FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Epic Pharma, LLC
Epic Pharma, LLC has obtained FDA approval for ANDA 203863 to manufacture hydrocodone bitartrate and acetaminophen, broadening the generic availability of this widely prescribed painkiller. This commercial launch is expected to intensify competition against branded opioid formulations and drive price reduction in the analgesic market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day